We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
    • Leafly.deGerman flag
  • Help
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
CanadaHealthStrains & products

Zenabis recalls mislabeled CBD gelcaps that actually contained THC

Jesse B. StaniforthPublished on December 20, 2019 · Last updated July 28, 2020
smileitsmccheeze/iStock

Since legalization, the two noteworthy types of cannabinoid labelling errors leading to recalls may be principally classified as “too much THC” and “not enough THC” (though they may also apply to CBD).

A labelling error that causes consumers to use weaker cannabis than they were expecting is, at least in the non-medical adult-use market, essentially a nuisance. The opposite problem—products containing far more THC than they are labelled to contain—is a more frightening prospect.

Unfortunately, Vancouver licensed producer Zenabis is going through just such a recall: their Namaste CBD Light gelcap products, supposed to each contain 0.19mg THC and 6.13mg CBD, actually contained 2.28mg THC and no CBD.

Some 165 units of the mislabelled gelcaps were sold in New Brunswick, through that province’s Crown monopoly Cannabis NB.

Though some on social media poked fun at the low dose of THC per capsule, others noted the gelcaps contained an equally low dose of CBD, suggesting consumers might be inclined to take more than one.

While incremental increases of less than 2.5mg are mild, three or four capsules taken together could be enough to cause impairment and potential discomfort to a person with no THC tolerance expecting only CBD.

This is Zenabis’s second such recall: previously, they recalled dry flower sold in Quebec that contained 17.3% THC and 0.07% CBD rather than the labelled 6.57% THC and 12.1% CBD.

Most licensed parties are focusing their attention, rightly or wrongly, on attracting new cannabis users, and many are happy the CBD boom is softening entrenched stigma and bringing new consumers into cannabis stores seeking CBD products.

That is, when they’ve been available to find them—LPs began the year having dramatically underestimated Canadians’ demand for CBD products.

At a moment when consumers are still exploring their relationships with CBD and other cannabis products, no LP wants to be known for sometimes containing an impairing amount of THC in products labelled to contain very little.

Watch Leafly TV

Click here to discover more videos on Leafly TV.

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
CanadahealthNew Brunswickstrains and products
Jesse B. Staniforth
Jesse B. Staniforth
Jesse Staniforth reports on cannabis, food safety, and Indigenous issues. He is the former editor of WeedWeek Canada.
View Jesse B. Staniforth's articles

The latest in Canada

  • Vancouver weed visitor’s guide 2024 image
    Vancouver weed visitor’s guide 2024
    Amelia Williams
  • A history of cannabis prohibition in Canada image
    A history of cannabis prohibition in Canada
    Emma Spears
  • Are psychedelics legal in Canada? image
    Are psychedelics legal in Canada?
    Colleen Fisher Tully
  • D8, Eh? What Canadians need to know about Delta-8 cannabis products image
    D8, Eh? What Canadians need to know about Delta-8 cannabis products
    Adam Greenblatt
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.